WHO agrees compensation fund for serious COVAX vaccine side effects
By Kate Kelland
LONDON (Reuters) – The World Health Organization has agreed a no-fault compensation plan for claims of serious side effects in people in 92 poorer countries due to get COVID-19 vaccines via the COVAX sharing scheme, resolving a big concern among recipient governments.
The programme, which the WHO said was the first and only vaccine injury compensation mechanism operating on an international scale, will offer eligible people “a fast, fair, robust and transparent process”, the WHO said in a statement.
“By providing a no-fault lump-sum compensation in full and final settlement of any claims, the COVAX programme aims to significantly reduce the need for recourse to the law courts, a potentially lengthy and costly process,” the statement said.
Questions of how compensation claims would be handled in the event of any serious COVID-19 vaccine side effects, which are likely to be very rare, had been a worry for countries due to get COVID-19 shots via the COVAX plan.
Countries funding their own COVID-19 vaccine procurement also plan their own liability programmes.
The WHO-agreed plan, which has been under discussion for several months, is designed to cover serious side effects linked to any COVAX-distributed vaccines until June 30, 2022, to COVAX’s Advance Market Commitment-eligible economies – a group of 92 poorer states which includes most African and Southeast Asian countries.
The programme will be financed initially from donor funding to the AMC as an extra charge on all doses of COVID-19 vaccines distributed through COVAX. Applications can be made via a portal at http://www.covaxclaims.com from March 31, 2021, the WHO said.
Seth Berkley, chief executive of the GAVI vaccine alliance which co-leads COVAX, said the agreement on the compensation fund was “a massive boost” for COVAX, which aims to secure equitable global access to COVID-19 vaccines.
“It helps those in countries who might have such effects, manufacturers to roll out vaccines to countries faster, and is a key benefit for lower-income governments procuring vaccines through (COVAX),” Berkley said.
The WHO said it was also working with the insurance firm Chubb to secure insurance coverage for the programme.
(Reporting by Kate Kelland; Editing by Alison Williams)
More Top Stories
Entire towns and communities along the route of the Keystone XL pipeline—once lively and prosperous due to the economic opportunity it brought—have been left out …read more
Feds flooding Yuma with illegal aliensread more
Thirty-four cases of pregnant women experiencing spontaneous miscarriages or stillbirths after receiving a COVID-19 vaccine have been submitted to the Vaccine Adverse Event Reporting System …read more
Teachers Union Allegedly Sends Emails To Racially Profile Los Angeles Parents Speaking To Media In Favor Of School Reopening
California’s largest teachers union has allegedly sent emails to racially profile parents who have spoken favorably to media about the Los Angeles school district reopening.read more
Officials with the United States Trade Representative Office (USTR) say they are considering a carbon border tax on foreign imports to help reduce greenhouse gas …read more
Scientists from at least thirty-three universities in the United Kingdom have worked with Chinese military researchers on the development of nuclear weapons, an investigation has …read more